The Australian share market is closed today for the Queen’s birthday. In the spirit of this holiday, I thought I would look for 10 ASX 200 shares that I think are fit for a queen.

The 10 shares I have chosen are listed below. Here’s why I think they should be in Buckingham Palace’s portfolio:

a2 Milk Company Ltd (ASX: A2M)

The first ASX 200 share to consider buying is a2 Milk Company. It is a New Zealand-based infant formula and fresh milk company with a focus on A2-only products. This point of difference has gone down well with consumers. This is particularly the case in China where it sales continue to grow rapidly. 

Afterpay Ltd (ASX: APT)

Another option to consider is Afterpay. I think this payments company could be a fantastic long term investment due to the way it is revolutionising the payments industry. It still has a significant runway for growth in the United States and opportunities to expand into mainland Europe and Asia.

Altium Limited (ASX: ALU)

Altium is an award-winning printed circuit board (PCB) design software provider. I think it is a standout buy due to its leading position in a market exposed to the Internet of Things boom. I expect the proliferation of electronic devices to lead to increasing demand for its software over the next decade.

Appen Ltd (ASX: APX)

Appen is another exciting ASX 200 share with enormous promise. Its million-plus team of crowd sourced experts prepare the data that goes into the artificial intelligence and machine learning models of some of the biggest tech companies in the world. Given how these markets are expected to grow materially in the future, Appen looks well-placed to profit.

Cochlear Limited (ASX: COH)

I think Cochlear would be another great option. It is one of the world’s leading hearing solutions companies and has a long track record of delivering earnings growth. I believe this trend will continue for a long time to come thanks to the ageing populations tailwind.

CSL Limited (ASX: CSL)

Another ASX 200 share which I would buy is CSL. I think the biotherapeutics company’s shares can continue to be market beaters over the next decade. This is due to the increasing demand for its immunoglobulins, its world class plasma collection network, growing demand for influenza vaccines, and its burgeoning research and development pipeline.

IDP Education Ltd (ASX: IEL)

I think it would be worth considering IDP Education. It is a provider of international student placement services and English language testing services. I’ve been very impressed at the way the company has been performing over the last few years and expect more of the same over the next decade.

Nanosonics Ltd (ASX: NAN)

Another ASX 200 share to consider buying is Nanosonics. I’m a big fan of the infection control specialist due to its very positive long term outlook. Its trophon EPR disinfection system for ultrasound probes has a massive market opportunity and could alone support solid earnings growth over the next decade. But the upcoming launch of new products make the investment proposition even more attractive.

REA Group Limited (ASX: REA)

REA Group is a digital advertising company that operates Australia’s leading property websites. It also operates real estate websites in Europe, Asia, and the United States. While trading conditions are tough now, I expect these headwinds to ease once the pandemic passes. And when they do, I believe its earnings growth will accelerate once again.

SEEK Limited (ASX: SEK)

A final ASX 200 share to consider buying is SEEK. I’m very positive on its long term outlook due to the strength of its core ANZ business and the growth potential of its international operations. This is particularly the  case with its China business. I believe it has the potential to underpin strong earnings growth over the next decade. 

More reading

• Is the Macquarie share price the best ASX bank to buy?
• 3 ASX 200 blue chip dividend shares to buy in June
• Could these sensational ASX shares help you beat the market?
• 3 top ASX 200 shares to buy next week
• 3 ASX shares for a stress-free life

James Mickleboro owns shares of SEEK Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Altium, Cochlear Ltd., CSL Ltd., Idp Education Pty Ltd, and Nanosonics Limited. The Motley Fool Australia owns shares of A2 Milk, AFTERPAY T FPO, and Appen Ltd. The Motley Fool Australia has recommended Cochlear Ltd., Nanosonics Limited, REA Group Limited, and SEEK Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post 10 ASX 200 shares that are fit for the Queen appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/377gHlm

The Macquarie Group Ltd (ASX: MQG) share price has been hit hard by the coronavirus concerns in 2020.

Macquarie shares slumped 52.41% lower between 21 February and 23 March as the S&P/ASX 200 Index (ASX: XJO) slumped into a bear market.

Investors were clearly worried about the pandemic’s impact on the Aussie banks.

We saw many banks report billion-dollar impairments while an oil price war also weighed on valuations.

But the Macquarie share price has been on a solid run and edged 0.42% higher in Friday’s trade. That means the ASX bank share climbed 7.30% higher in the last week.

So, with all the volatility, is Macquarie the best bank share to buy today?

Why the Macquarie share price could be a bargain

I like to look at the relative value of Macquarie versus its other major bank peers.

The National Australia Bank Ltd (ASX: NAB) share price is down 20.91% in 2020. Similarly, Westpac Banking Corp (ASX: WBC) shares have fallen 22.45% lower this year.

In contrast, the Macquarie share price is down 14.40%. That says to me that investors are somewhat more bullish on Macquarie versus the other ASX banks.

That could be for good reason, too. Macquarie isn’t so much a retail bank as it is a business and investment bank.

That means Macquarie generates significant earnings from investments like infrastructure and its corporate banking compared to home loans for the other ASX banks.

No one knows if that will be a good or bad thing in 2020. However, I think diversified and strategic investments could translate to some big wins for Macquarie.

The Macquarie share price closed at $118.00 per share on Friday. That means a price to earnings (P/E) ratio of 13.86 right now.

That makes it about on par with Westpac (14.11) and cheaper than NAB (17.48) right now.

Foolish takeaway

There’s no such thing as a sure thing in ASX bank shares right now. However, the Macquarie share price could be a cheap relative buy if it outperforms its major bank peers in 2020.

More reading

• 10 ASX 200 shares that are fit for the Queen
• 3 ASX 200 blue chip dividend shares to buy in June
• 3 top ASX 200 shares to buy next week
• Where I’d invest $2,500 in ASX shares today
• Top brokers name 3 ASX 200 shares to sell next week

Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Is the Macquarie share price the best ASX bank to buy? appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2AJHN63